We examined whether CXCL12α improves insulin secretion by influencing the Ca 2+ oscillation pattern and Ca
IntRoduCtIon
Diabetes is characterized either by a near-absolute absence (type 1 diabetes; T1D) or depletion (type 2 diabetes; T2D) of pancreatic β-cells that is responsible for the condition that is described by insufficient or impaired insulin secretion. Therefore, β-cell mass regulation and improved β-cell viability and function through the stimulation of insulin secretion represent a focal point for prospective diabetes management.
Insulin secretion from the pancreatic β-cells induced primarily by glucose is mediated by the known mechanism that involves: raising the ratio of ATP/ ADP, closing the ATP-sensitive K + (K ATP ) channels leading to plasma membrane depolarization, voltage-gated calcium (Ca v ) channels activation and increased Ca 2+ influx ([Ca 2+ ] i ) [1] . Finally, increased [Ca 2+ ] i triggers the exocytosis of insulin-containing granules. There is extensive literature that examines the relationship between β-cell electrical activity and intracellular Ca 2+ concentration, both in the islets of Langerhans and in isolated islet cells [2] [3] [4] [5] [6] . Increased glucose concentration induces several types of cyclical spike activity and Ca 2+ oscillations with different periods in insulin-secreting cells [7] . The Ca 2+ oscillations are closely linked to multiple key aspects of β-cell functioning in physiological and pathological conditions. There are several Ca 2+ oscillation types: "fast", with a period from several seconds to one minute, "slow", with a period ranging from one to several minutes and "mixed" (or compound) oscillations characterized by fast oscillations superimposed on slow oscillations [8] . Numerous hormones, small molecule agonists as well as toxins can change the Ca 2+ oscillatory behavior of β-cells thereby influencing [Ca 2+ ] i and insulin secretion.
Results obtained from β-cell research recently highlighted the important role of CXC chemokine ligand12 (CXCL12) in enhancing β-cell viability and proliferation. This positioned CXCL12 as a potentially important molecule for the treatment of diabetes. CXCL12 belongs to the CXC group of chemokines. It was first discovered as a pre-B cell growth-stimulating factor [9, 10] that is also important for the proper formation of multiple organ systems. It has a significant role in tissue development, repair and regeneration [11] [12] [13] . CXCL12 is a ligand for two transmembrane receptors: CXCR4 and CXCR7 [14, 15] . It was shown to stimulate β-cell survival by preventing apoptosis via activation of the prosurvival kinase Akt, which consequently upregulates the expression of antiapoptotic protein Bcl-2 and phosphorylates the proapoptotic protein Bad [16] . Transgenic mice overexpressing CXCL12 in their β-cells are resistant to β-cell apoptosis and diabetes. Our laboratory revealed a CXCL12-mediated improvement of β-cell viability, which is based on CXCL12 antinecrotic action through the modulation of PARP-1 activity [17] . Furthermore, CXCL12 is involved in the regulation of insulin secretion [18] . Since diabetes results from an insufficient number of β-cells or a lack of their functionality, the important role of CXCL12 in the process of increased β-cell viability and boosting of insulin secretion in the pancreas is of particular interest for the potential treatment of diabetes.
The present work sought to investigate if and by which mechanism CXCL12 signaling could confer insulinotropic effects under physiological and oxidative stress conditions in the intact islets of Langerhans. We hypothesized that the delivery of CXCL12 to intact mouse Langerhans islets would improve viability and increase insulin secretion, influencing the Ca 2+ oscillation pattern, [Ca 2+ ] i and overall concentration of the Ca 2+ in the cytosol.
MAteRIAls And Methods

Animals
All protocols followed the regulations approved by the Animal Care Committee of the Universidad Miguel Hernández according to national and European policies about ethics in animal research. Swiss albino OF1 mice (8-10 weeks old) were used.
Isolation of mouse pancreatic islets
Swiss albino OF1 male mice were killed by cervical dislocation and pancreatic islets were isolated by collagenase (Sigma, Madrid, Spain) digestion as previously described [19] . Briefly, islet isolation was performed in Hank's balanced salt solution (HBSS; 115 mM NaCl, 10 mM NaHCO 3 , 5 mM KCl, 1.2 mM NaH 2 PO 4 , 25 mM HEPES, 1.1 mM MgCl 2 ) containing 1% (wt/vol) bovine serum albumin (BSA; fraction V) (Sigma, Madrid, Spain) and 5 mM glucose. The pancreas was cannulated by infusion of a 10-mL solution of 1.0 mg/ mL collagenase in supplemented HBSS into the common bile duct. The distended pancreas was excised, transferred to a flask tube and incubated at 37°C with 1.0 mg/mL of collagenase in supplemented HBSS for 20 min. The digestion was stopped by adding cold supplemented HBSS solution. Using a dissection microscope and an external light source, the islets were handpicked (handpicking was repeated three times). The islets were cultured in groups in RPMI 1640 without phenol red at 37°C in a humidified atmosphere of 95% O 2 and 5% CO 2 for 48 h. The medium was supplemented with 10% fetal bovine serum (Thermo Scientific), 2 mM L-glutamine, 200 U/mL penicillin and 0.2 mg/mL streptomycin. To obtain single islet cell suspensions, the isolated islets were collected and washed in PBS before dispersal by mechanical shaking at 37°C for 3 min in 0.05% trypsin, 0.7 mM EDTA. The enzymatic reaction was stopped by the addition of RPMI 1640 culture medium, and after centrifugation at 400 x g for 10 min, the cells were washed in PBS and placed in the appropriate medium, depending on the experimental protocol.
Pancreatic islet cell viability assay
Viability of islet cells was determined by simultaneously staining live and dead cells using a two-color fluorescence staining: acridine orange (AO) and propidium iodide (PI). Live cells stained green, while dead cells stained red. A working solution was prepared (0.6 µL AO from 5mg/mL and 10 µL PI from 1mg/ mL stock solutions) in 1 mL PBS. Dye mix (25 µl) was added to the cell suspension and transferred to a microscope slide. Cells were visualized using Leica DMLB fluorescence microscope.
5-bromo-2ʹ-deoxyuridine (Brdu) incorporation
The isolated islets were dispersed into single cells with trypsin/EDTA as described above. 
Calcium imaging
The isolated pancreatic islets were incubated in the presence of 5 µM fura-2-acetoxymethyl ester (Fura-2 AM; Molecular Probes) for at least 1 h at room temperature in a modified HBSS buffer (pH 7. The results were plotted and analyzed using commercially available software (Sigmaplot, Jandel Scientific).
Rt-qPCR analysis
Isolated pancreatic islets of Langerhans served as control, nontreated or incubated in 40 ng/mL of CXCL12α for 30 min and 12 h. Total RNA from the control and CXCL12α-treated islets was extracted using the RNeasy Mini Kit (74106, Qiagen). For cDNA synthesis, 1 μg of the total RNA was reverse-transcribed using the QuantiTect Rev. Transcription Kit (205311, Qiagen) and oligo(dT) primers. For RT-qPCR the Maxima SYBR Green/ROX qPCR Master Mix (Fermentas) was used. mRNA levels were quantitatively determined with an ABI Prism 7000 Sequence Detection system (Applied Biosystems). The fragments were amplified using the following primer sets: upstream 5ʹ-GAT-TCTTTGAGAGCCATGTC-3ʹ and downstream 5ʹ-GTCTGTTGTTGCTTTTCAGC-3ʹ for the rat Cxcl12 gene; upstream 5ʹ-CTGACTGGTACTTT-GGGAAA-3ʹ and downstream 5ʹ-GGAACACCAC-CATCCACAGG-3ʹ for the rat Cxcr4 gene; upstream 5ʹ-ATGTGCTGCTGTATACCCTC-3ʹ and downstream 5ʹ-GTGATGACGACCCACAGATC-3ʹ for the rat Cxcr7 gene; upstream 5ʹ-CAAGCTGGAGAA-GAATGAGG-3ʹ and downstream 5ʹ-TCACCTGTTC-CTCAAGGGAG-3ʹ for the rat Trpm2 gene; upstream 5ʹ-AACGGCACCCTCTTACCTTT-3ʹ and downstream 5ʹ-TGCTGACATAGGACCTGCTG-3ʹ for the rat Lc type of calcium channel gene (CACNA1c); upstream 5ʹ-AAGAGGACCTGGCAGATGAA-3ʹ and downstream 5ʹ-TTGAGCATTTTCCTCCCAAC-3ʹ for the rat Ld type of calcium channel gene (CACNA1d); upstream 5ʹ-AGATTACTGCCCTGGCTC-CT-3ʹ and downstream 5ʹ-ACATCTGCTGGAAG-GTGGAC-3ʹ for the rat β-actin gene. The real-time PCR program for quantitative RT-PCR was as follows: an initial step at 50°C for 2 min, followed by an initial denaturation step at 95°C for 10 min and a subsequent two-step PCR program at 95°C for 15 s and at 60°C for 60 s for 40 cycles. Negative controls lacking the template were used in all RT-qPCR reactions. The expression levels of target genes were related to the averaged expression level of rat β-actin as the housekeeping gene.
Measurement of insulin secretion
For insulin secretion, the 48-h-cultured islets were washed for 2 h with a modified HBSS buffer (pH 7.35) when gassed with 95% O 2 and 5% CO 2 . Groups of 5 islets were then transferred to 400 µl of a buffer solution containing (in mmol/L) 140 NaCl, 4.5 KCl, 2.5 CaCl 2 , 1 MgCl 2 , 20 HEPES and the corresponding concentration of glucose (3, 8 or 11 mmol/L), with a final pH of 7.4. Subsequently, 100 μL of the buffer solution with the corresponding glucose concentration and 5% BSA was added, followed by incubation at room temperature for 3 min and a cool-down period of 15 min on ice. Then the medium was collected, and the insulin content was measured in duplicate samples via radioimmunoassay (RIA) using a Coat-a-Count kit (Siemens, Los Angeles, CA, USA). The protein concentration was measured using the Bradford dye method [20] .
statistical analysis
Data are expressed as the mean±SEM. Pairwise comparisons were made using the Student's t-test, unless stated otherwise. A probability level of p<0.05 was considered statistically significant.
Results
CXCl12α exerts proliferative and prosurvival effects on pancreatic islet cells
To examine the beneficial effect of CXCL12α on pancreatic β-cells, the islets of Langerhans were isolated from male OF1 mice and pretreated with 40 ng/mL of CXCL12α prior to exposure to 7.5 µM hydrogen peroxide, which served to induce oxidative stress ( Fig.  1 ). The proliferative potential of the pretreatment with CXCL12α was validated by BrdU incorporation for 48 h, followed by double-staining with anti-BrdU and anti-insulin antibodies (Fig. 1A) . Statistically significant increases in the number of double-stained BrdU and insulin positive cells after the pretreatment of islets with CXCL12α as compared to control cells were observed (inset in Fig. 1A ). Overnight incubation of the islets decreased cell viability to about 70%, whereas the treatment with hydrogen peroxide decreased cell viability further, which was observed as a 15% higher number of dead cells (Fig. 1B) . However, when the islets were incubated overnight with 40 ng/mL of CXCL12α and exposed to oxidative stress, their viability remained at the control level. This result shows that CXCL12α provided for an increased proliferative potential and improved the ability of β-cells to withstand oxidative stress. ] i of islet cells consecutively treated with 7.5 µM of hydrogen peroxide. Isolated islets were preloaded with Fura-2AM and intracellular calcium-dependent fluorescence was measured. The physiological response was initiated with 11 mM of D-glucose (11G) and challenged with successive islet treatment with 7.5 μM of hydrogen peroxide (3G-3 mM D-glucose). The insets represent one islet captured during the calcium imaging (a -phase contrast microscopy) stained with EtBr homodimer after the measurement (b). One representative result from three independent experiments is shown. *p value from Student's t-test <0.05.
CXCl12α preserves islet cell functionality by normalizing their Ca 2+ response under oxidative stress
To assess the functionality of β-cells under oxidative stress, we analyzed the rise in [Ca 2+ ] i that primes cells for insulin release. [Ca 2+ ] i served as a dynamic parameter of islet functionality in response to stimulatory glucose concentration. In our experimental setup, we first examined whether a 7.5-µM concentration of hydrogen peroxide influences [Ca 2+ ] i . Isolated islets were preloaded with Fura-2 AM and subjected to calcium imaging (Fig. 1C) ] i , indicating unresponsiveness of the islet cells to glucose stimulus.
To check whether CXCL12α increases cell viability by influencing Ca 2+ influx, isolated islets were incubated overnight with 40 ng/mL of CXCL12α, preloaded with Fura-2 AM and subjected to calcium imaging. Islet viability was challenged with 25 mM KCl, which depolarizes the cell membrane and impedes Ca 2+ influx. The control islets exhibited the usual response to a high glucose challenge, observed as an increase in intracellular Ca 2+ concentration ( Fig. 2A) . In contrast, islets treated with 7.5 µM hydrogen for 1 h exhibited decreased responsiveness to the high D-glucose treatment (Fig. 2B) , displayed as an irregular Ca 2+ spike followed by an oscillatory pattern. When the same experimental setup was applied to islets that were incubated overnight with 40 ng/mL of CXCL12α prior to exposure to 7.5 µM hydrogen peroxide for 1 h (Fig.  2C) , the CXCL12α-pretreated islets exhibited a physiological response to high glucose that was comparable to the response elicited in control islets. The protective capacity of CXCL12α was further tested on islets that were exposed to a 10-fold higher concentration (75 µM) of hydrogen peroxide. This concentration of hydrogen peroxide, which induced a high level of oxidative stress, initiated widespread cell death, so that the islet cells were unable to properly respond to the high D-glucose concentration (Fig. 2D) . The pretreatment of islet cells with CXCL12α did not preserve cell functionality at the level of oxidative stress induced by 75 µM hydrogen peroxide (Fig. 2E) . dependent fluorescence was measured in control islets (A) and islets treated with a 7.5-µM hydrogen peroxide concentration (B, D) with and without overnight islet incubation with CXCL12α (40 ng/mL) (C, E). The islet's membrane depolarization was induced with 25 mM KCl, while the islet's physiological response was initiated with 11 mM of glucose. One representative result from three independent experiments is shown.
CXCl12α modulates Ca 2+ oscillations in islet cells in response to high glucose
The deterioration of pancreatic β-cell function over time in T2D is the consequence of poor glycemic control and the continuous exposure of β-cells to the deleterious effects of reactive oxygen species (ROS). We examined whether CXCL12α could improve the response of pancreatic islet cells in the hyperglycemic state. To that end, [Ca 2+ ] i was monitored in isolated islets preloaded with Fura-2 AM (Fig. 3) . As can be seen in Fig. 3A , when islets were treated with 3 mM of D-glucose supplemented with 40 ng/mL of CXCL12α, their intracellular Ca 2+ concentration did not change, and islet functionality was preserved, which was confirmed by their response to the high, 11-mM Dglucose concentration. When islets were exposed to a moderate to high, 8-mM D-glucose concentration (Fig. 3B) ] i (inset in Fig. 3B ). The same result was obtained when islet cells were challenged with 11 mM of D-glucose (Fig. 3C) . In this setup, the islets were probed with 11 mM D-glucose, as well as in combination with two CXCL12α concentrations (20 and 40 ng/ mL). Treatments with both CXCL12α concentrations decreased the number of oscillations that also lasted longer, which pointed to an overall increase in [Ca 2+ ] i (inset in Fig. 3C) , with the 40-ng/mL CXCL12α concentration showing a more significant effect.
CXCl12α signaling influences the expression of voltage-gated Ca 2+ channels in pancreatic islets
The ] i led us to assume that the CXCL12α/receptor axis regulates the behavior of the Ca v channels. To examine this fur- ther, isolated islets were incubated either for 30 min or overnight with 40 ng/mL of CXCL12α, and their mRNA was isolated (Fig. 4) . CXCL12 acts via two receptors, CXCR4 and CXCR7. RT-qPCR experiments revealed that the mRNAs encoding for both receptors were significantly increased after the 30-min incubation of islets with CXCL12α (Fig. 4) . The overnight incubation with CXCL12α induced a 2-fold increase in CXCR4 mRNA, while the level of CXCR7 mRNA was unchanged. This result revealed that CXCR7 gene transcription was considerably lower in islets as compared to CXCR4 gene transcription. Further, RT-qPCR experiments revealed that CXCL12α also induced insulin mRNA synthesis in islet cells. The exposure of islets to CXCL12α for 30 min induced a 4-fold increase in insulin mRNA synthesis, while overnight islet incubation with CXCL12a did not cause a significant increase in insulin gene transcription.
Next, we analyzed the expression of voltage-gated L-type Ca 2+ channels that belong to the high-threshold type of channels and are opened by large depolarizations, that contribute to the β-cell Ca 2+ current and insulin secretion. After the 30-min incubation with CXCL12α, the mRNAs for both Lc and Ld subtypes were significantly increased (2.5-and 6-fold, respectively). The overnight incubation with CXCL12α induced less pronounced but significant increases in Lc and Ld mRNAs (Fig. 4) . We also analyzed the Ca 2+ -permeable, nonselective cation channel TRPM2, which is gated by intracellular ADP-ribose and has a key role in hydrogen peroxide-induced Ca 2+ transients and cell death [21] . In pancreatic islets under physiological conditions, TRPM2 mRNA was barely detectable. After the 30-min incubation with 40 ng/ mL of CXCL12α, a small, insignificant increase was observed (Fig. 4) , and after the overnight incubation with CXCL12α, a significant decrease in TRPM2 gene transcription was measured, pointing to the prosurvival effect of CXCL12α in islet cells.
CXCl12α stimulated insulin release in the hyperglycemic state
An increase in blood glucose concentrations induces a series of cellular events leading to the depolarization of the β-cell plasma membrane that opens Ca V channels to mediate Ca 2+ influx and stimulate insulin secretion. In the next set of experiments we examined whether the increase in [Ca 2+ ] i , observed after the incubation of pancreatic islets with CXCL12α, was also linked with insulin secretion. The islets were incubated either for 30 min (Fig. 5A) or overnight ( Fig. 5B ) with 40 ng/mL of CXCL12α, followed by treatment with 8 mM and 11 mM of D-glucose, and their insulin secretion was measured by RIA. Under physiological conditions, in the presence of 3 mM of D-glucose, CXCL12α did not affect insulin secretion. Stimulatory glucose concentrations induced increased insulin secretion, further enhanced in the presence of CXCL12α (Fig. 5) . Incubation with CXCL12α for 30 min induced significant insulin release after ex- posure to 8 mM and 11 mM of D-glucose (compared to matching controls, 2.18-and 1.53-fold increases, respectively; Fig. 5A ). The overnight incubation of islets with CXCL12α induced significant but slightly lower increases in insulin secretion after exposure to 8 mM and 11 mM of D-glucose (compared to matching controls, 1.59-and 1.35-fold increase, respectively) compared to the 30-min incubation with CXCL12α (Fig. 5B) . These findings underlined that the presence of CXCL12α in the cell medium increases insulin release in islets by enhancing Ca 2+ uptake.
dIsCussIon
Hyperglycemia contributes to the reduction of insulin secretion and to the progression from glucose intolerance to T2D [22] , causing pancreatic β-cell dysfunction and decreasing the β-cell mass [23, 24] . Therefore, β-cell protection remains the focus of strategies for the prevention and treatment of diabetes [25] . In general, the diabetogenic environment, including insulin resistance and low-grade systemic islet inflammation contribute toward the stunning of pancreatic β-cells, i.e. a state of temporary incapacity to properly respond to the presence of increased glucose concentration by secreting insulin [26] . The aim of the present study was to examine whether CXCL12α exhibits a beneficial effect on pancreatic β-cells' ability to release insulin and whether it improves the response of pancreatic islets in the hyperglycemic state.
Antidiabetic action of CXCl12α: normalizing Ca 2+ uptake in order to preserve the functionality of islets
In overweight and obese individuals, pancreatic β-cells are exposed to metabolic changes and the consequences thereof, including oxidative stress resulting from increased ROS and RNS production. As a ligand of two receptors, CXCR4 and CXCR7, CXCL12 signaling is crucial for β-cell differentiation and pancreatic islet genesis [27] . Recent animal studies revealed the essential role of CXCL12 in duct cell survival, proliferation and migration during pancreatic regeneration, through its ability to activate Akt, Src and the extracellular signal-regulated protein kinase (ERK1/2) [28] . Our group also showed that the role of CXCL12 in diabetes attenuation is based on its ability to activate the antinecrotic/prosurvival pathway after hydrogen peroxide treatment [17] . In this study, we examined oxidative stress as a potential inducer of β-cell dysfunction [29] . Both effects, proliferative burst and increased survival rate of pancreatic β-cells, observed after islet incubation with CXCL12α could be accomplished by the direct influence of CXCL12 on intracellular Ca 2+ influx.
It is widely accepted that exogenous ROS induces dynamic changes in Ca 2+ concentration in a variety of cell types [30] [31] [32] [33] [34] [35] . This effect could be due to the mobilization of intracellular Ca 2+ stores and influx of extracellular Ca
2+ . An important feature of crossregulation between ROS and Ca 2+ is that the ROS effect on Ca 2+ signaling can vary from stimulatory to repressive, depending on the type of oxidants, their concentrations and the duration of exposure. The ef- fect of ROS on Ca 2+ signaling is also tissue-specific (reviewed in [36] ). We found that CXCL12α preserves mouse islet functionality by normalizing their Ca 2+ response under oxidative stress (hydrogen peroxide treatment). In contrast, islet cell treatment with a 10-times higher concentration of hydrogen peroxide (75 µM) induced a constant entry of Ca 2+ , which indicated cell death as a consequence of exposure to the very high concentration of peroxide treatment. This finding is in accordance with previous studies showing that hydrogen peroxide causes an increase in intracellular Ca 2+ levels that leads to cell death in a variety of cell types [37] [38] [39] [40] [41] . The mechanism whereby hydrogen peroxide causes an increase in [Ca 2+ ] i is still under debate, with several options proposed, including the involvement of voltage-gated Ca 2+ channels (Ca v ) [41] , nonspecific changes in membrane calcium permeability [42] , alteration in Na + -Ca 2+ exchange [38] , or changes in Ca 2+ release from intracellular stores [43] . Using the insulin-secreting cell line CRI-G1 and very high hydrogen peroxide concentrations (1-10 mM), Herson et al. [44] described the effects of hydrogen peroxide on [Ca 2+ ] i . They clearly demonstrated that hydrogen peroxide disrupts calcium homeostasis. In contrast, it has also been reported that hydrogen peroxide exerts no significant effect on the L-type Ca 2+ current in pancreatic β-cells [45] .
On the other hand, a chronic exposure of pancreatic islets to nonphysiological high glucose concentrations caused adverse alterations in β-cell functioning in a phenomenon referred to as glucose toxicity, which may play a secondary pathogenic role in T2D. Several results suggested that one mechanism of glucose toxicity in β-cells may be linked to chronic exposure of cells to ROS (or chronic oxidative stress) [46] [47] [48] . Both low and high concentrations of glucose have been shown to increase intracellular peroxide levels within the islets [49] , which indicates that glucose metabolism is essential for the induction of glucose toxicity. This is in agreement with Ihara et al. [50] , who reported elevated levels of oxidative stress markers (8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins) in the β-cells of Goto-Kakizaki rats. Our experimental setup is suitable for observing β-cell behavior in hyperglycemic conditions, since chronic hyperglycemia causes a progressive decline in β-cell functioning and their ultimately demise [26, 51] .
Electrical activity and stimulated secretion, coupled with intracellular Ca 2+ dynamics that allow pancreatic β-cells to secrete insulin, first reported by Dean and Matthews in 1968 [52] , are nowadays accepted [53] [54] [55] . Cells often respond to changes in stimulus intensity by varying the frequency of Ca 2+ waves. To demonstrate the rescue potential of CXCL12α in preventing β-cell dysfunction and exhaustion due to sustained hyperglycemia, mouse pancreatic islets were exposed to stimulatory glucose concentrations, both moderate to high (8 M) and high (11 M) , for an average duration of 45 min [56, 57] . In our study, the treatment of β-cells with CXCL12α in hyperglycemic conditions decreased the number and duration of Ca ] i . It has been already shown that CXCL12 stimulates Ca 2+ flux and transients in many cell types [58] [59] [60] . Similar to our finding, CXCL12 dose-dependently increased intracellular Ca 2+ in adherent IEC-6 cells in the concentrations of 20 and 100 ng/mL [61] . Chemokineinduced Ca 2+ mobilization was not solely a function of rat intestinal epithelial cells, since CXCL12 stimulated a rapid increase in Ca 2+ within 40 s of ligand stimulation in the intestinal carcinoma cell line CaCo 2 cells as well [61] . In human LX2 cells, treatment with CXCL12 led to a nearly two-fold increase in relative Ca 2+ influx, whereas in murine JS1 cells CXCL12 did not promote Ca 2+ movement [62] . The latter authors showed that the CXCL12-influenced hepatic stellate cell contraction is not Ca 2+ dependent. In addition, the Ca 2+ -influenced CXCL12 secretion has also been investigated. Schajnovitz et al. [63] reported that Ca 2+ is transmitted via gap junctions in contacting cell cultures, and that Ca 2+ signaling has a role in bone marrow stromal cell CXCL12 secretion.
CXCl12α signaling influences the expression of voltage-gated Ca
2+ channels in pancreatic islets and stimulates insulin release in the hyperglycemic state
In a high-glucose environment and/or in the presence of ROS, voltage-gated Ca 2+ (Ca v ) channels are activated, allowing extracellular Ca 2+ to enter [64] [65] [66] [67] . It is generally accepted that the subsequent increase in cytosolic Ca 2+ triggers insulin release, even though there is some evidence for a [Ca 2+ ] i -independent second phase of insulin release [68] . Thus, regulation of Ca v activity and/or density may result in lower or higher insulin secretion [69] [70] [71] [72] [73] [74] [75] [76] [77] . Insulin release must be able to anticipate glucose increase and prevent persistent glucose elevations [26, 78] . Insulin secretion analysis in rat insulinoma and primary islet cells revealed that Nand L-type channels are both involved in immediate glucose-induced insulin secretion. However, L-type Ca v channel was preferentially coupled to secretion at a later phase. P/Q-type channels were not found to play any role in insulin secretion at any stage [79] . [77] , although the Lc and Ld subtypes share almost a 70% homology [80] . In agreement with previous reports, herein we showed that CXCL12α increases the transcription rate of Ca v L-type channels, in particular Ld-type, which contains the α1D subunit and represents the Ca v 1.3α1 channel subtype. We also observed an increase in N-type channels due to the increased presence of CXCL12. The increased transcriptional rate for the N-type of channels was significant but 7.2-fold less pronounced as compared to the increase in the transcriptional rate for the L-type Ca v channels (data not shown). In contrast, Barg et al. [81] found no differences in Ca 2+ -current density and Cav1.3/ α1D-deficient β-cells, and concluded that Cav1.2 is the principal L-type Ca 2+ channel subtype in mouse β-cells. The functional consequences of the increase in Ca v channel transcription rate may be relevant in diseases, such as T2D, since β-cells operate with very few Ca v channels [55, 82] . The observed CXCL12α-related influence could provide β-cells with a mechanism to push Ca 2+ -coupled regulation of insulin secretion in response to elevated glucose.
Since [Ca 2+ ] i dynamics are also responsible for β-cell fate [55] , we examined whether the Trpm2 Ca 2+ channel is upregulated due to an excess of CXCL12α. Trpm2, a calcium-permeable nonselective cation channel expressed in the plasma membrane is critically involved in ROS-induced processes and is implicated in cell death [83] . In contrast to Ca v channels, CXCL12α has no influence on the transcription rate of Trpm2 after 30 min of incubation, in contrast to overnight incubation, which caused a lowering of the transcription of the Trpm2 channel gene. The primary gating mechanism of Trpm2 involves the binding of ADP-ribose polymers (ADPR) [84] , but Trpm2 currents can also be activated by reactive oxygen species (ROS) [85] through ROS-induced ADPR release from mitochondria [86] . Bearing in mind that the role of Trpm2 in pancreatic β-cells involves situations in which β-cells are stressed [87, 88] , the observed downregulation of Trpm2 mRNA in our experiments is not surprising. As a small chemokine, CXCL12 exerts its effect via coupling to its receptors, CXCR4 and CXCR7. The 30-min incubation with CXCL12α was followed by an increase in the level of Cxcr4 mRNA. The increased Ca 2+ influx in islet cells was accompanied by increased transcription of the Cxcr7 and Ins. Our RT-qPCR results showed significantly increased transcription of both receptor genes after islet incubation with CXCL12α, targeting CXCR4 as the most important receptor responsible for signaling within the islet. This is in accordance with previous reports indicating that CXCL12 is involved in the regulation of insulin secretion [89] . β-cell injury induces CXCL12 expression and the secreted CXCL12 causes dedifferentiation of adjacent -cells into pro-α-cells, which are further transformed into pancreatic β-cells [18, 90] . β-cell Ca v channel activity can be modulated by changes in membrane potential and through a variety of signaling pathways, such as protein phosphorylation, Ca 2+ -dependent inactivation and through interaction with G protein (reviewed in [91] ). The observation that CXCL12α is capable to modify Ca 2+ oscillations and increase [Ca 2+ ] i as well as influence the transcription of Lc and Ld Ca 2+ channel genes, led us to assume that the CXCL12α/receptor axis regulates the behavior of the Ca v channels. Princen et al. [92] showed that a transient dose-dependent increase in intracellular Ca 2+ concentration is an essential component of the signal transduction cascade activated upon CXCL12 binding to its receptor CXCR4. The authors showed that in all examined CXCR4 + cell lines, CXCL12 elicited a transient [Ca 2+ ] i increase. For each cell line, the magnitude of the response was related to the level of CXCR4 expression. Published data suggest that CXCR4 signaling may not be limited to the G-protein-coupled receptor (GPCR) Gαi, and that CXCR4 can couple to other Gα protein subunits such as Gαq, Gαo, and Gαs in order to stimulate Ca 2+ flux [93] . However, it has been proven that Ca 2+ flux is associated with the GPCR subunit Gαq but not to Gαi [94] . Quite the opposite, Hsu et al. [95] proposed that the L-type Ca v channel in insulin-secreting cells is the major mediator of the somatostatin-induced inhibition of insulin secretion by the activation of G proteincoupled receptors. In the same line, Renstrom et al. [96] reported that stimulation of GPCRs in mouse islet β-cells does not influence the voltage activated Ca 2+ influx. Our assumption of the CXCL12/receptor axis being a mediator in the elevated voltage activated Ca 2+ influx in pancreatic β cells is supported by Roe et al. [97] , who reported that decreased L-type channel activity and expression were associated with T2D.
Defects in the metabolic regulation of insulin secretion contribute to the development of T2D. Rescuing stunned β-cells is possibly a key therapeutic target for the treatment and prevention of diabetes progression. It seems reasonable to propose that bringing any degree of hyperglycemia under tight control as early as possible can switch on stunned β-cells, in spite of the fact that glycemic memory and genetic/epigenetic programming may differ in every individual. Identification of the factors that regulate the overall Ca 2+ intake, activity and expression of Ca v channels and insulin release may provide a better understanding of pancreatic β-cell functioning in normal and diabetic states. CXCL12 displayed the potential to regulate [Ca 2+ ] i and the transcription of Ca v channel genes and thus may serve as a potential T2D attenuator.
